Background Major depressive disorder (MDD) is a common condition with a lifetime
prevalence of 15% to 18%, which leads to considerable suffering and disability. Some …

Background Dysthymia is a depressive disorder of chronic nature but of lower severity than
major depression. Depressive symptoms are more or less continuous for at least two years …

Background Depressive symptoms, often of substantial severity, are found in 50% of newly
diagnosed suffers of schizophrenia and 33% of people with chronic schizophrenia who have …

Background Antipsychotics are widely used in the treatment of major depressive disorder
(MDD), but there has been no comprehensive meta-analytic assessment that examined their …

Background Evidence is limited regarding the most effective pharmacological treatment for
psychotic depression: combination of an antidepressant plus an antipsychotic, monotherapy …

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to
huge impacts on direct and indirect personal and public medical costs. To overcome such a …

Background Anxiety disorders are common and disabling conditions, with a lifetime
prevalence of 17% in the general population. Due to high rates of treatment resistance, there …

Less than one third of patients who suffer from major depressive disorder (MDD) report
remission following antidepressant treatments requiring more diverse treatment approaches …

INTRODUCTION: Chronic depression represents a substantial portion of depressive
disorders and is associated with severe consequences. This review examined the efficacy …

Background Negative symptoms are common in people with schizophrenia and are often
difficult to treat with antipsychotic drugs. Treatment often involves the use of various add‐on …